Clinical Trial Update: Tricalcium Phosphate and Chitosan as Bone Regenerator Versus Autologous Graft in Surgery for Mandibular Fracture [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tricalcium phosphate and chitosan bone regenenerator to autologous graft for mandibular fracture repair has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mandibular Fractures

Drugs mentioned

• Autologous graft
• Tricalcium phosphate and chitosan bone regenerator

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Mandibular Fractures | Phase 3 | Status: COMPLETED